Why Chicken IgY? Chicken polyclonal antibodies have become indispensible research tools. There are many benefits to using a chicken host for antibody production: higher titer against mammalian gene products, stronger signal, easier multiplexing, high yields, and more. Read all about chicken IgY science, advantages, and production in our Chicken Antibodies 101 resource.
"The service offered by Aves Labs was excellent. Both administrative and technical staff were always available to answer our questions and help in any way possible." ~Elizabeth Fidalgo da Silva, PhD., University of Windsor
ANTIBODIES THAT WORK
- Aves Labs has over 20 years of expertise in chicken antibody development.
- Chicken IgY antibodies boast high yields, better specificity and easy multiplexing.
- Lots of happy researchers. Read some of our customer success stories!
- Check out some of the researchers who have published using our custom services.
COMPREHENSIVE SUPPORT
- Customer support from the scientist making your antibody.
- Full-service antibodies, including: conjugation, antibody production, and antibody purification.
- Complimentary peptide design and synthesis using our proprietary Immunogenicity Algorithm® for optimal immune response.
ETHICAL ANIMAL TREATMENT
- Antibodies purified from the egg yolks of immunized hens.
- Repeated animal bleeds are unnecessary, and restraints are only used once - at injection.
- High yield with fewer animals - a single hen can produce large amounts of antibody in eggs for an extended period of time.
Service Packages
We offer three service packages for peptide synthesis and custom antibody production. You can also select the purity level and quantity of your antibody, the number of hens to be immunized, and optional ELISA characterization. Contact us with your project details. We look forward to providing you with a speedy project consultation and quote!
Package #1:
Custom Polyclonal
Antibody Production
Antibodies generated against a customer-supplied antigen.
Estimated Timeframe
4 month production protocol
Includes:
- Purified immune IgY from two (2) hens (~800 mg IgY / hen)
- Pre-immune IgY from each hen (~150 mg of IgY / hen)
- Four (4) Immunizations per hen
Package #2:
Custom Peptide and
Antibody Production
Affinity-purified antibodies generated against a synthesized peptide.
Estimated Timeframe
4-6 month production protocol
Includes:
- Peptide design
- Peptide synthesis up to twenty (20) residues
- Conjugation to KLH
- Affinity purification pooled from both hens
- ELISA analysis
- Pre-immune IgY (~150 mg) from each hen
- Remaining peptides (~20 mg)
Package #3:
Custom Phosphospecific Peptide
and Antibody Production
Affinity purified antibodies against a phosphospecific peptide.**
Estimated Timeframe
4-6 month production protocol
Includes:
- Peptide synthesis of non-phosphorylated peptide
- Peptide synthesis of phosphorylated peptide
- Conjugation to KLH
- Positive affinity purification
- Negative affinity purification
- ELISA analysis
- Remaining peptides (~20 mg)
Injection and Purification Timelines
Standard Protocol (est. 3-4 months*)
*Add 4-6 weeks if requesting peptide synthesis
*Additional boosts (optional). Add 5-6 weeks.
View Timeline Details - Chicken Polyclonals
Includes:
Immunogen Selection (Variable timeline)
- Determination of optimal immunogen for your project.
- You can supply your own immunogen or we can work together to design and synthesize a peptide immunogen that meets your criteria (species reactivity, degree of reactivity with related proteins etc.).
Immunization Schedule (7-8 weeks)
- Purified Immune IgY from two (2) chickens (approx. 800 mg of IgY per hen)
- Pre-Immune IgY from each chicken (~150 mg of IgY per hen)
- Four (4) immunizations per animal.
ELISA Report (1 week)
- Eggs are collected and IgY is analyzed by ELISA and compared to the pre-immune eggs to evaluate titer (recommended).
IgY Purification (1 week)
- Twelve (12) eggs are used to prepare purified IgY using our proprietary protocol yielding an IgY preparation that is >90% pure.
- The purified IgY prep can be used in most common applications (immunohistochemistry, immunocytochemistry, Western blotting etc.).
- To obtain only antigen-specific binders, the IgY prep can be further subjected to affinity purification.
Affinity Purification - optional (2 weeks)
- The IgY fraction is subjected to antigen-specific affinity purification yielding an antigen-specific antibody preparation that is >90% pure.
FAQs
Where do I start?
If you are supplying ready-to-inject antigen (e.g., recombinant protein), please provide us with a description of the antigen (type, size, buffer, etc.) and simply ship us the antigen along with a copy of our Polyclonal Antibody Production Order Form.
- For research scale production (i.e., two hens), we suggest 4.0 mg of protein in a total volume of 4.0 mLs of PBS or TBS (i.e., 1.0 mg/mL). It is best if the protein is placed in four 1.0 mL aliquots and frozen on dry ice. If you only have a precious amount of protein, we likely can use a concentration of 0.5 mg/mL.
- If your ready-to-inject antigen is in a buffer solution other than PBS or TBS, please be sure that the buffer does not contain high concentrations of urea (greater than 0.5 M), SDS (greater than 1% (w/v), imidazole (greater than 10 mM), EDTA/EGTA (greater than 100 mM), or sodium azide (greater than 0.01%). All of these agents are irritants and may cause the hens to cease egg production.
- If you would like us to affinity purify the antibodies, send an additional 5 mg of antigen in PBS. Since we use primary amine chemistry to conjugate most proteins to matrix, these preparations must not contain any Tris buffer, which interferes with this chemistry.
- If you supply us with peptide, we will need to conjugate the peptide to a carrier protein such as keyhole limpet hemocyanin (KLH). Please include sequence information to help us choose the best conjugation options and peptide solubilization strategy. We require 5-10 mg of peptide for conjugation to carrier protein, and another 5-10 mg of peptide for conjugation to affinity matrix.
Please contact us with questions about these or other chemicals in your antigen preparations.
What is the recommended number of hens?
Since chickens are outbred species (like rabbits), we highly recommended injecting at least two hens. From that starting point, the number of hens to be injected depends on the amount of antibody you require as well as the hens' inherent immunogenicity.
Can you help with antigen design?
Yes! Just send us the sequence or the accession number. We will perform the analysis and present you with options. We provide this service to new clients for a $200 analysis fee, which we credit to your account should the project move forward.
I'd like to send my own antigen. How should I prepare it?
Here are some general guidelines on protein size, protein concentration, buffers, other chemicals in the buffers, and form of the protein:
Protein Size
In general, the immune system does not recognize small molecules, so there is a minimum size for a protein to become "immunogenic."
- We recommend that the proteins under 20 kDa in size (about 200 amino acids) be coupled to something bigger in order to make them maximally immunogenic.
- Treat the protein with a bi-functional cross-linking agent, such as glutaraldehyde or paraformaldehyde, or conjugate the protein to keyhole limpet hemocyanin (KLH).
Protein Concentration
It is difficult to predict what concentration of protein is necessary to inject due to differences in the immunogenicity of the proteins. In general, the more, the better.
- We recommend using at least 2 mg of protein in a total volume of 5000 uL of buffer.
- This is high for highly immunogenic proteins, but with poorly immunogenic proteins, it is likely necessary.
Buffers
The ideal buffer for injections is phosphate-buffered (10 mM, pH 7.2) isotonic saline (also called "PBS").
- Freund used this buffer so many years ago when he was perfecting his adjuvants.
- It does not contain primary amine groups -- which will interfere with conjugations to smaller molecules that use aldehydes or NHS-groups.
- Tris buffered saline ("TBS") is fine for injections as well, but it contains a primary amine group, such that it cannot be used when conjugations are required.
Other Chemicals in the Buffer
Given the technical nature of this issue, please contact us to discuss your particular buffer.
- If a chemical is toxic or an irritant to hens, it should not be present.
- Tris and imidazole (anything below 5 mM), chemicals that are commonly found in some preparations, are fine for inclusion.
- Detergents disrupt the emulsification needed to create a good adjuvant, and should be dialyzed away. This includes both ionic detergents (e.g., SDS) and non-ionic detergents (e.g., triton X-100, tween-20, etc.).
- Don't worry if your protein comes out of solution, insoluble proteins often make the best preparations for antibody production!
Form of the Protein
We can inject proteins either in solution or in polyacrylamide gels.
- For proteins in solution: put your protein into PBS at a concentration of 2 mg in 5000 uL (400 ug/mL). Do not put in anti-microbials, such as sodium azide, or other agents that will harm or irritate the hens.
- For proteins in polyacrylamide gels: if your protein is contaminated with other proteins, you might want to run an SDS-polyacrylamide gel to separate the protein of interest from the contaminants. Please see our FAQ for details on sending gel slices.
What if my protein precipitates in PBS?
Insoluble proteins generally make great antigens, so don’t worry if your protein comes out of solution in PBS. Simply make an even suspension before aliquoting your antigen.
The reason is not entirely clear, but it may be that insoluble proteins remain at the site of injection for a longer period, allowing them to interact with the antigen-presenting cells. Therefore, it is good news if your protein comes out of solution while making your injection mixture!
How should I prepare my antigen in a gel slice?
- Run a thick gel (at least 1 mm in width).
- Visualize your protein: Do not fix the protein inside the gel with an irreversible stain, and is important not to fix the gels with ethanol-acetic acid. We recommend Pierce Zinc Reversible Stain Kit from Thermo or use a light Coomassie dye to identify protein location to assist in removing the proper gel slices.
- Once the gel is stained, the staining solution should be removed, allowing the protein to diffuse from the gel and stimulate the immune system.
- Be sure to minimize the volume of the gel itself. When preparing gel slices cut out 5 equal slices, transfer each slice to separate microfuge tube and add 1X PBS to 1 mL total in each tube to prevent gel from drying out.
What is emulsification?
Emulsification is the process by which miscelles of aqueous buffer that contain the protein become surrounded by oil. This process allows the protein to be released slowly into the hen's connective tissue, which is the preferred time for delivery for antibody production. This process is important to make a good adjuvant.
What are the antibody purity options?
We offer two options for antibody purity. The first option, the "IgY" fraction", is IgY in PBS and contains only a small fraction against the antigen of interest. This may be sufficient for some applications such as Western blot and ICC.
The second option, affinity purified antibodies, are the IgY fraction purified against an affinity matrix, resulting in the entire antibody recognizing the antigen. This is required for applications such as IP.
What matrix do you use for affinity purification?
We find that agarose-based matrices provide the lowest non-specific binding and highest capacities for affinity purification. These matrices are chemically-modified to allow covalent attachment of antigen via either primary amine or sulfhydryl groups.
Do you offer ELISA testing?
We can perform an ELISA assay, which provides information about antibody titres and antibody avidities for the antigen. This information can help provide guidance about antibody dilutions in your studies.
How much antibody will I receive?
After delivering antibody preparations to you, we can continue to collect and store approximately twelve (12) immune eggs for a period of two (2) months. These eggs can be used to prepare additional batches of antibodies at a significantly reduced cost. You may also choose to have us continue boosting the hens to collect additional batches of eggs.
Phosphospecific chicken polyclonals
Chickens are a particularly useful host animal for this production of phosphospecific antibodies because of the virtually unlimited supply of starting material. Typically, phosphopeptide antibody projects performed in rabbits are limited by the amounts of serum available. With chicken eggs as the starting material, there is considerably more antibody to begin with.
First, we with customers in phosphopeptide design to balance high immunogenicity of the sequence with a high proportion of antibody that is specific to the phosphorylated form of the peptide (i.e., doesn’t cross-react with the non-phosphorylated form).
Next, a KLH-conjugated form of the phosphopeptide is injected into laying hens. After a 6-8 week boosting period, the IgY fraction is purified from the egg yolks. Finally, an affinity purification is performed using a phosphopeptide-agarose column, followed by a negative affinity purification using a second column bound with the non-phosphorylated form of the peptide. This negative affinity purification removes remaining antibodies that are not phosphospecific.
Related Services
CUSTOM RECOMBINANT ANTIBODIES
- Recombinant antibodies prevent genetic drift, produce a higher yield, and can be generated in alternate species.
- Convert your favorite monoclonal antibody to a recombinant version!
CUSTOM MONOCLONAL ANTIBODIES
- Tried and true - monoclonal antibodies have broad utility in therapeutics, diagnositics, and research.
- We are experts in hybridoma technology and tailor our service to your needs!
CUSTOM PHOSPHOSPECIFIC ANTIBODIES
- Phosphospecific antibodies can detect the phosphorylation state of a protein.
- Our scientists are experts in phosphorylation - from peptide antigen design to purification to ELISA characterization.
Publications Using Our Custom Services
| PMID | Publication |
| 39679679 | Hanford, HE, et al. 2024. Inhibition and evasion of neutrophil microbicidal responses by Legionella longbeachae. mBio, e0327424. |
| 38672278 | Zhao, L, et al. 2024. Chemerin in Participants with or without Insulin Resistance and Diabetes. Biomedicines, 0. |
| 39251552 | Donninger, H., et al. 2024. NORE1A loss promotes MASLD/MASH. Transgenic Research, . |
| 38823470 | Midavaine, É, et al. 2024. Discovery of a CCR2-targeting pepducin therapy for chronic pain. Pharmacological Research, 107242. |
| 38802868 | Talsma, AD, et al. 2024. Neither injury induced macrophages within the nerve, nor the environment created by Wallerian degeneration is necessary for enhanced in vivo axon regeneration after peripheral nerve injury. Journal of Neuroinflammation, 134. |
| 38134511 | Ochwoto, M., et al. 2023. Cytoarchitecture of ex vivo midgut cultures of unfed Ixodes scapularis infected with a tick-borne flavivirus. Ticks Tick Borne Diseases, 102301. |
| 37981423 | Tahara, U, et al. 2023. Keratinocytes of the Upper Epidermis and Isthmus of Hair Follicles Express Hemoglobin mRNA and Protein. The Journal of investigative dermatology, 2346-2355.e10. |
| 37720106 | Rose, K.P., et al. 2023. Spatially distinct otic mesenchyme cells show molecular and functional heterogeneity patterns before hearing onset. iScience, 107769. |
| 36781220 | Gregoriou, G.C., et al. 2023. Opioid withdrawal abruptly disrupts amygdala circuit function by reducing peptide actions. Journal of Neuroscience, 1668-1681. |
| 36448839 | Castro-Córdova, P., et al. 2023. Redistribution of the Novel Clostridioides difficile Spore Adherence Receptor E-Cadherin by TcdA and TcdB Increases Spore Binding to Adherens Junctions. Infection and Immunity, e0047622. |
| 35379362 | Winkler, C.W., et al. 2022. Zika virus vertical transmission in interferon receptor1-antagonized Rag1−/− mice results in postnatal brain abnormalities and clinical disease. Acta Neuropathology Communications, 46. |
| 35326270 | Brašić, J.R., et al. 2022. Fragile X Mental Retardation Protein and cerebral expression of metabotropic glutamate receptor subtype 5 in men with fragile X syndrome: A pilot study. Brain Science, 314. |
| 35182405 | Nonnecke, E.B., et al. 2022. Human intelectin‐2 (ITLN2) is selectively expressed by secretory Paneth cells. FASEB Journal, e22200. |
| 35029299 | Baldicano, A.K., et al. 2022. Retinal ganglion cells expressing CaM kinase II in human and nonhuman primates. Journal of Comparative Neurology, 1470-1493. |
| 34622958 | Nasir‐Ahmad, S., et al. 2022. Satb1 expression in retinal ganglion cells of marmosets, macaques, and humans. Journal of Comparative Neurology, 923-940. |
| 34468815 | Ton, T.V.T., et al. 2021. Cobalt-induced oxidative stress contributes to alveolar/bronchiolar carcinogenesis in B6C3F1/N mice. Archives of Toxicology, 3171-3190. |
| 34145348 | Nonnecke, E.B., et al. 2021. Human intelectin-1 (ITLN1) genetic variation and intestinal expression. Scientific Reports, 12889. |
| 32725281 | Kahng, S.J., et al. 2020. Carbon nanotube-based thin-film resistive sensor for point-of-care screening of tuberculosis. Biomedical Microdevices, 50. |
| 32255763 | Carrisoza-Gaytan, R., et al. 2020. Intercalated cell BKα subunit is required for flow-induced K+ secretion. JCI Insight, e130553. |
| 32179647 | Yadav, P.K., et al. 2020. Thioredoxin regulates human mercaptopyruvate sulfurtransferase at physiologically-relevant concentrations. Journal of Biological Chemistry, 6299-6311. |
| 32099918 | Harper, M.M., et al. 2020. Identification of chronic brain protein changes and protein targets of serum auto-antibodies after blast-mediated traumatic brain injury. Heliyon, e03374. |
| 31363993 | LeBlanc, B.M., et al. 2019. Structural properties and cellular expression of AfrLEA6, a group 6 late embryogenesis abundant protein from embryos of Artemia franciscana. Cell Stress Chaperones, 979-990. |
| 31275378 | Chavez-Cortez, E.G., et al. 2019. Production and evaluation of an avian IgY immunotoxin against CD133+ for treatment of carcinogenic stem cells in malignant glioma: IgY immunotoxin for the …. Journal of Oncology, 2563092. |
| 30973903 | Gerhart, J., et al. 2019. Rhabdomyosarcoma and Wilms tumors contain a subpopulation of noggin producing, myogenic cells immunoreactive for lens beaded filament proteins. PLoS One, e0214758. |
| 30161155 | Zhao, L., et al. 2018. Dynamic and tissue-specific proteolytic processing of chemerin in obese mice. PLoS One, e0202780. |
| 29973268 | Zhao, L., et al. 2018. Chemerin 156F, generated by chymase cleavage of prochemerin, is elevated in joint fluids of arthritis patients. Arthritis Research and Therapy, 132. |
| 29903915 | Emerman, A.B., et al. 2018. The RNA-binding complex ESCRT-II in Xenopus laevis eggs recognizes purine-rich sequences through its subunit, Vps25. Journal of Biological Chemistry, 12593-12605. |
| 29760438 | Kotila, T., et al. 2018. Structural basis of actin monomer re-charging by cyclase-associated protein. Nature Communications, 1892. |
| 29505961 | Patel, N.S., et al. 2018. Identification of new PDE9A isoforms and how their expression andásubcellular compartmentalization in the brain change across the life span. Neurobiology of Aging, 217-234. |
- Opens in a new window.
